Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Nosocomial blood stream infections in patients treated with venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome.

Kutleša M, Santini M, Krajinović V, Papić N, Novokmet A, Josipović Mraović R, Baršić B.

Minerva Anestesiol. 2017 May;83(5):493-501. doi: 10.23736/S0375-9393.17.11659-7. Epub 2017 Jan 25.

2.

Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.

Samuel N, Id Said B, Guha T, Novokmet A, Li W, Silwal-Pandit L, Børrsen-Dale AL, Langerød A, Hudson TJ, Malkin D.

Hum Mutat. 2017 Mar;38(3):265-268. doi: 10.1002/humu.23154. Epub 2017 Jan 23.

PMID:
27957778
3.

Venovenous extracorporeal membrane oxygenation for ARDS: outcome analysis of a Croatian referral center for respiratory ECMO.

Kutleša M, Novokmet A, Josipović Mraović R, Baršić B.

Wien Klin Wochenschr. 2017 Jul;129(13-14):497-502. doi: 10.1007/s00508-016-1109-3. Epub 2016 Nov 7.

PMID:
27822747
4.

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.

Samuel N, Wilson G, Lemire M, Id Said B, Lou Y, Li W, Merino D, Novokmet A, Tran J, Nichols KE, Finlay JL, Choufani S, Remke M, Ramaswamy V, Cavalli FM, Elser C, Meister L, Taylor MD, Tabori U, Irwin M, Weksberg R, Wasserman JD, Paterson AD, Hansford JR, Achatz MI, Hudson TJ, Malkin D.

J Clin Oncol. 2016 Aug 22. pii: JCO676940. [Epub ahead of print]

PMID:
27551116
5.

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D.

Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.

PMID:
27501770
6.

Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.

Id Said B, Kim H, Tran J, Novokmet A, Malkin D.

Hum Mutat. 2016 Sep;37(9):889-92. doi: 10.1002/humu.23025. Epub 2016 Jun 27.

PMID:
27297285
7.

Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

Wasserman JD, Novokmet A, Eichler-Jonsson C, Ribeiro RC, Rodriguez-Galindo C, Zambetti GP, Malkin D.

J Clin Oncol. 2015 Feb 20;33(6):602-9. doi: 10.1200/JCO.2013.52.6863. Epub 2015 Jan 12.

8.

Extracorporeal membrane oxygenation treatment for H1N1-induced acute respiratory distress syndrome (ARDS): results of the Croatian Referral Center for Respiratory ECMO.

Kutleša M, Novokmet A, Josipovic Mraovic R, Filar B, Mardešic P, Baršic B.

Int J Artif Organs. 2014 Oct;37(10):748-52. doi: 10.5301/ijao.5000356. Epub 2014 Oct 14.

PMID:
25361183
9.

Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.

Merino DM, Shlien A, Villani A, Pienkowska M, Mack S, Ramaswamy V, Shih D, Tatevossian R, Novokmet A, Choufani S, Dvir R, Ben-Arush M, Harris BT, Hwang EI, Lulla R, Pfister SM, Achatz MI, Jabado N, Finlay JL, Weksberg R, Bouffet E, Hawkins C, Taylor MD, Tabori U, Ellison DW, Gilbertson RJ, Malkin D.

Clin Cancer Res. 2015 Jan 1;21(1):184-92. doi: 10.1158/1078-0432.CCR-14-1324. Epub 2014 Oct 21.

10.

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE.

Cancer. 2015 Jan 15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15.

11.

Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D.

Cancer. 2014 Apr 1;120(7):1068-75. doi: 10.1002/cncr.28507. Epub 2013 Dec 30. Erratum in: Cancer. 2014 Jun 15;120(12):1910.

12.

Routine TP53 testing for breast cancer under age 30: ready for prime time?

McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D.

Fam Cancer. 2012 Dec;11(4):607-13. doi: 10.1007/s10689-012-9557-z.

PMID:
22851211
13.

Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors.

Walker EJ, Zhang C, Castelo-Branco P, Hawkins C, Wilson W, Zhukova N, Alon N, Novokmet A, Baskin B, Ray P, Knobbe C, Dirks P, Taylor MD, Croul S, Malkin D, Tabori U.

Cancer Res. 2012 Feb 1;72(3):636-44. doi: 10.1158/0008-5472.CAN-11-2266. Epub 2011 Dec 5.

14.

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, Novokmet A, Finlay J, Malkin D.

Lancet Oncol. 2011 Jun;12(6):559-67. doi: 10.1016/S1470-2045(11)70119-X. Epub 2011 May 19.

PMID:
21601526
15.

A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes.

Shlien A, Baskin B, Achatz MI, Stavropoulos DJ, Nichols KE, Hudgins L, Morel CF, Adam MP, Zhukova N, Rotin L, Novokmet A, Druker H, Shago M, Ray PN, Hainaut P, Malkin D.

Am J Hum Genet. 2010 Nov 12;87(5):631-42. doi: 10.1016/j.ajhg.2010.10.007.

16.

Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.

Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, Novokmet A, Malkin D.

Cancer Res. 2010 Jan 1;70(1):160-71. doi: 10.1158/0008-5472.CAN-09-1902.

17.

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.

Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11264-9. doi: 10.1073/pnas.0802970105. Epub 2008 Aug 6.

Supplemental Content

Loading ...
Support Center